Clues on Clovis

A Bloomberg story suggesting Clovis Oncology Inc. (NASDAQ:CLVS) looked for - but did not find a buyer - last month has weighed on the company's shares. But a further decline last week likely had more to do with data for a competitor's cancer compound.